Physician profile
David Brouwer
NPI 1629018544
$45,841.86
in general payments reported to CMS, 2019-2025
12 companies · $90.09 in 2025
The $90.09 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $61.68 · 2021: $43.37 · 2022: $56.85 · 2023: $288 · 2024: $293 · 2025: $90.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $44,989.15 | 2019 | |
| Abbvie INC. | $395.06 | 2021-2024 | Ubrelvy, Synthroid, Qulipta |
| Glaxosmithkline, LLC. | $130.97 | 2019-2025 | Shingrix, Arexvy |
| Amgen INC. | $119.27 | 2020-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $43.01 | 2023-2024 | |
| Astellas Pharma US INC | $42.25 | 2024-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $26.07 | 2024 | |
| Boston Scientific Corporation | $25.24 | 2024 | |
| Lilly USA, LLC | $19.89 | 2025 | Zepbound, Mounjaro |
| Amarin Pharma, INC. | $18.41 | 2020 | |
| Endogastric Solutions, INC | $16.92 | 2024 | Esophyx |
| Allergan, INC. | $15.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brouwer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.